Aurora Kinase A - Cancer Science

Relevant Publications

Proximity-based activation of AURORA A by MPS1 potentiates error correction.

Issue Release: 2024

Pharmacological inhibition of protein kinase D2/Aurora kinase A signalling axis suppresses G2/M cell cycle progression and proliferation of epithelial ovarian cancer cells.

Issue Release: 2024

Aurora kinase A is overexpressed in human retinoblastoma and correlates with histopathological high-risk factors: implications for targeted therapy.

Issue Release: 2024

Cell Death in Leishmania donovani promastigotes in response to Mammalian Aurora Kinase B Inhibitor- Hesperadin.

Issue Release: 2024

Clinical analysis of 10 cases with subcutaneous panniculitis-like T-cell lymphoma and tissue AURKA expression.

Issue Release: 2024

Involvement of Endolysosomes and Aurora Kinase A in the Regulation of Amyloid β Protein Levels in Neurons.

Issue Release: 2024

Coupling Kinesin Spindle Protein and Aurora B Inhibition with Apoptosis Induction Enhances Oral Cancer Cell Killing.

Issue Release: 2024

ReCorDE: a framework for identifying drug classes targeting shared vulnerabilities with applications to synergistic drug discovery.

Issue Release: 2024

Knowledge mapping of AURKA in Oncology：An advanced Bibliometric analysis (1998-2023).

Issue Release: 2024

The Cell Cycle: a Key to Unlock EZH2-targeted Therapy Resistance.

Issue Release: 2024

A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.

Issue Release: 2024

Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. 2022, , 876.

Issue Release: 2024

Combination of an aurora kinase inhibitor and the ABL tyrosine kinase inhibitor asciminib against ABL inhibitor-resistant CML cells.

Issue Release: 2024

Mouse KL2 is a unique MTSE involved in chromosome-based spindle organization and regulated by multiple kinases during female meiosis.

Issue Release: 2024

PLK1 inhibition leads to mitotic arrest and triggers apoptosis in cholangiocarcinoma cells.

Issue Release: 2024

Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer.

Issue Release: 2024

Microtubule end-on attachment maturation regulates Mps1 association with its kinetochore receptor.

Issue Release: 2024

Transcription Factor ETV4 Activates AURKA to Promote PD-L1 Expression and Mediate Immune Escape in Lung Adenocarcinoma.

Issue Release: 2024

Aurora kinase A-mediated phosphorylation triggers structural alteration of Rab1A to enhance ER complexity during mitosis.

Issue Release: 2024

Deletion of Aurora kinase A prevents the development of polycystic kidney disease in mice.

Issue Release: 2024

What is Sunflower Oil?

What are Cancer Public Health Policies?

What Are Some Commonly Amplified Genes in Cancer?

How is the Hedgehog Pathway Related to Cancer?

How is Lung Inflammation Diagnosed?

Can Testosterone Therapy Increase Cancer Risk?

Why Do People Use GoFundMe for Cancer?

How Is Artificial Intelligence Contributing to Cancer Treatment?

What Are the Implications for Research and Development?

Who Can Benefit from Guaranteed Issue Policies?

Aurora Kinase A - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics